Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tau Brain Imaging in Typical and Atypical Alzheimer's Disease
NCT03022968Phase 2Completed
- Sponsor
- University Hospital Tours
- Start
- Jan 2017
- Primary completion
- Aug 2019
- Countries
- 1
01
Overview
Phase 2, open-label trial (3 arms), sponsored by University Hospital Tours. Primary endpoints: Tau density on PET imaging at 3 months and Tau distribution on PET imaging at 3 months. Started Jan 2017; status: completed.
Beyond the preview
Go deeper on NCT03022968.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03022968.